Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

This study is currently recruiting participants.

Study NCT00082862 Information provided by National Cancer Institute (NCI)

First Received: May 14, 2004 Last Updated: April 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2012 (Final data collection date for primary outcome measure)